Skip to main content
Top
Published in: Pediatric Nephrology 1/2021

01-01-2021 | Kidney Transplantation | Original Article

Effects of COVID-19 pandemic on pediatric kidney transplant in the United States

Authors: Olga Charnaya, Teresa Po-Yu Chiang, Richard Wang, Jennifer D. Motter, Brian J. Boyarsky, Elizabeth A. King, William A. Werbel, Christine M. Durand, Robin K. Avery, Dorry L. Segev, Allan B. Massie, Jacqueline M. Garonzik-Wang

Published in: Pediatric Nephrology | Issue 1/2021

Login to get access

Abstract

Background

In March 2020, COVID-19 infections began to rise exponentially in the USA, placing substantial burden on the healthcare system. As a result, there was a rapid change in transplant practices and policies, with cessation of most procedures. Our goal was to understand changes to pediatric kidney transplantation (KT) at the national level during the COVID-19 epidemic.

Methods

Using SRTR data, we examined changes in pediatric waitlist registration, waitlist removal or inactivation, and deceased donor and living donor (DDKT/LDKT) events during the start of the disease transmission in the USA compared with the same time the previous year.

Results

We saw an initial decrease in DDKT and LDKT by 47% and 82% compared with expected events and then a continual increase, with numbers reaching expected prepandemic levels by May 2020. In the early phase of the pandemic, waitlist inactivation and removals due to death or deteriorating condition rose above expected values by 152% and 189%, respectively. There was a statistically significant decrease in new waitlist additions (IRR 0.49 0.65 0.85) and LDKT (IRR 0.17 0.38 0.84) in states with high vs. low COVID activity. Transplant recipients during the pandemic were more likely to have received a DDKT, but had similar calculated panel–reactive antibody (cPRA) values, waitlist time, and cause of kidney failure as before the pandemic.

Conclusions

The COVID-19 pandemic initially reduced access to kidney transplantation among pediatric patients in the USA but has not had a sustained effect.
Literature
2.
go back to reference Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med 382:929–936. https://doi.org/10.1056/NEJMoa2001191CrossRefPubMedPubMedCentral Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G, Cohn A, Fox L, Patel A, Gerber SI, Kim L, Tong S, Lu X, Lindstrom S, Pallansch MA, Weldon WC, Biggs HM, Uyeki TM, Pillai SK (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med 382:929–936. https://​doi.​org/​10.​1056/​NEJMoa2001191CrossRefPubMedPubMedCentral
4.
go back to reference Boyarsky BJ, Po-Yu Chiang T, Werbel WA, Durand CM, Avery RK, Getsin SN, Jackson KR, Kernodle AB, Van Pilsum Rasmussen SE, Massie AB, Segev DL, Garonzik-Wang JM (2020) Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant. https://doi.org/10.1111/ajt.15915 Boyarsky BJ, Po-Yu Chiang T, Werbel WA, Durand CM, Avery RK, Getsin SN, Jackson KR, Kernodle AB, Van Pilsum Rasmussen SE, Massie AB, Segev DL, Garonzik-Wang JM (2020) Early impact of COVID-19 on transplant center practices and policies in the United States. Am J Transplant. https://​doi.​org/​10.​1111/​ajt.​15915
11.
go back to reference Massie AB, Boyarsky BJ, Werbel WA, Bae S, Chow EK, Avery RK, Durand CM, Desai N, Brennan D, Garonzik-Wang JM, Segev DL (2020) Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: a stochastic simulation and machine learning study. Am J Transplant. https://doi.org/10.1111/ajt.16117 Massie AB, Boyarsky BJ, Werbel WA, Bae S, Chow EK, Avery RK, Durand CM, Desai N, Brennan D, Garonzik-Wang JM, Segev DL (2020) Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: a stochastic simulation and machine learning study. Am J Transplant. https://​doi.​org/​10.​1111/​ajt.​16117
16.
go back to reference Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A, Banker SL, Giordano M, Manice CS, Diamond R, Sewell TB, Schweickert AJ, Babineau JR, Carter RC, Fenster DB, Orange JS, McCann TA, Kernie SG, Saiman L (2020) Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children’s hospital in New York City, New York. JAMA Pediatr. https://doi.org/10.1001/jamapediatrics.2020.2430 Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A, Banker SL, Giordano M, Manice CS, Diamond R, Sewell TB, Schweickert AJ, Babineau JR, Carter RC, Fenster DB, Orange JS, McCann TA, Kernie SG, Saiman L (2020) Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children’s hospital in New York City, New York. JAMA Pediatr. https://​doi.​org/​10.​1001/​jamapediatrics.​2020.​2430
19.
go back to reference Prezelin-Reydit M, Combe C, Harambat J, Jacquelinet C, Merville P, Couzi L, Leffondré K (2019) Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: results from the French transplant database. Nephrol Dial Transplant 34:538–545. https://doi.org/10.1093/ndt/gfy039CrossRefPubMed Prezelin-Reydit M, Combe C, Harambat J, Jacquelinet C, Merville P, Couzi L, Leffondré K (2019) Prolonged dialysis duration is associated with graft failure and mortality after kidney transplantation: results from the French transplant database. Nephrol Dial Transplant 34:538–545. https://​doi.​org/​10.​1093/​ndt/​gfy039CrossRefPubMed
23.
go back to reference Boyarsky BJ, Werbel WA, Durand CM, Avery RK, Jackson KR, Kernodle AB, Snyder J, Hirose R, Massie IM, Garonzik-Wang JM, Segev DL, Massie AB (2020) Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. https://doi.org/10.1111/ajt.16167 Boyarsky BJ, Werbel WA, Durand CM, Avery RK, Jackson KR, Kernodle AB, Snyder J, Hirose R, Massie IM, Garonzik-Wang JM, Segev DL, Massie AB (2020) Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic. Am J Transplant. https://​doi.​org/​10.​1111/​ajt.​16167
24.
go back to reference Molnar MZ, Bhalla A, Azhar A, Tsujita M, Talwar M, Balaraman V, Sodhi A, Kadaria D, Eason JD, Hayek SS, Coca SG, Shaefi S, Neyra JA, Gupta S, Leaf DE Kovesdy CP, STOP, -COVID Investigators (2020) Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States. Am J Transplant. https://doi.org/10.1111/ajt.16280 Molnar MZ, Bhalla A, Azhar A, Tsujita M, Talwar M, Balaraman V, Sodhi A, Kadaria D, Eason JD, Hayek SS, Coca SG, Shaefi S, Neyra JA, Gupta S, Leaf DE Kovesdy CP, STOP, -COVID Investigators (2020) Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States. Am J Transplant. https://​doi.​org/​10.​1111/​ajt.​16280
Metadata
Title
Effects of COVID-19 pandemic on pediatric kidney transplant in the United States
Authors
Olga Charnaya
Teresa Po-Yu Chiang
Richard Wang
Jennifer D. Motter
Brian J. Boyarsky
Elizabeth A. King
William A. Werbel
Christine M. Durand
Robin K. Avery
Dorry L. Segev
Allan B. Massie
Jacqueline M. Garonzik-Wang
Publication date
01-01-2021
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 1/2021
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-020-04764-4

Other articles of this Issue 1/2021

Pediatric Nephrology 1/2021 Go to the issue